Guba M - Search Results

1

Surgical treatment of pNET - Experience of a "high-volume" center.

Bösch F, Hofmann K, Coenen M, Pratschke S, Thomas M, Knösel T, Bruns CJ, Guba M, Werner J, Angele MK. Bösch F, et al. Among authors: guba m. Surg Oncol. 2018 Sep;27(3):409-414. doi: 10.1016/j.suronc.2018.05.027. Epub 2018 May 29. Surg Oncol. 2018. PMID: 30217295

2

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor.

Guba M, von Breitenbuch P, Steinbauer M, Koehl G, Flegel S, Hornung M, Bruns CJ, Zuelke C, Farkas S, Anthuber M, Jauch KW, Geissler EK. Guba M, et al. Nat Med. 2002 Feb;8(2):128-35. doi: 10.1038/nm0202-128. Nat Med. 2002. PMID: 11821896

3

Vascular endothelial growth factor in colorectal cancer.

Guba M, Seeliger H, Kleespies A, Jauch KW, Bruns C. Guba M, et al. Int J Colorectal Dis. 2004 Nov;19(6):510-7. doi: 10.1007/s00384-003-0576-y. Epub 2004 Mar 4. Int J Colorectal Dis. 2004. PMID: 14999511 Review.

4

Blockage of 2-deoxy-D-ribose-induced angiogenesis with rapamycin counteracts a thymidine phosphorylase-based escape mechanism available for colon cancer under 5-fluorouracil therapy.

Seeliger H, Guba M, Koehl GE, Doenecke A, Steinbauer M, Bruns CJ, Wagner C, Frank E, Jauch KW, Geissler EK. Seeliger H, et al. Among authors: guba m. Clin Cancer Res. 2004 Mar 1;10(5):1843-52. doi: 10.1158/1078-0432.ccr-1176-3. Clin Cancer Res. 2004. PMID: 15014039

5

Rapamycin-induced endothelial cell death and tumor vessel thrombosis potentiate cytotoxic therapy against pancreatic cancer.

Bruns CJ, Koehl GE, Guba M, Yezhelyev M, Steinbauer M, Seeliger H, Schwend A, Hoehn A, Jauch KW, Geissler EK. Bruns CJ, et al. Among authors: guba m. Clin Cancer Res. 2004 Mar 15;10(6):2109-19. doi: 10.1158/1078-0432.ccr-03-0502. Clin Cancer Res. 2004. PMID: 15041732

6

Vascular endothelial growth factor in esophageal cancer.

Kleespies A, Guba M, Jauch KW, Bruns CJ. Kleespies A, et al. Among authors: guba m. J Surg Oncol. 2004 Aug 1;87(2):95-104. doi: 10.1002/jso.20070. J Surg Oncol. 2004. PMID: 15282704 Review.

7

Inhibition of SRC tyrosine kinase as treatment for human pancreatic cancer growing orthotopically in nude mice.

Yezhelyev MV, Koehl G, Guba M, Brabletz T, Jauch KW, Ryan A, Barge A, Green T, Fennell M, Bruns CJ. Yezhelyev MV, et al. Among authors: guba m. Clin Cancer Res. 2004 Dec 1;10(23):8028-36. doi: 10.1158/1078-0432.CCR-04-0621. Clin Cancer Res. 2004. PMID: 15585638

8

Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGF.

Guba M, Yezhelyev M, Eichhorn ME, Schmid G, Ischenko I, Papyan A, Graeb C, Seeliger H, Geissler EK, Jauch KW, Bruns CJ. Guba M, et al. Blood. 2005 Jun 1;105(11):4463-9. doi: 10.1182/blood-2004-09-3540. Epub 2005 Jan 25. Blood. 2005. PMID: 15671443 Free article.

9

FTY720 inhibits tumor growth and angiogenesis.

Schmid G, Guba M, Papyan A, Ischenko I, Brückel M, Bruns CJ, Jauch KW, Graeb C. Schmid G, et al. Among authors: guba m. Transplant Proc. 2005 Jan-Feb;37(1):110-1. doi: 10.1016/j.transproceed.2004.12.278. Transplant Proc. 2005. PMID: 15808563

10

Biochemical monitoring of mTOR inhibitor-based immunosuppression following kidney transplantation: a novel approach for tailored immunosuppressive therapy.

Hartmann B, Schmid G, Graeb C, Bruns CJ, Fischereder M, Jauch KW, Heeschen C, Guba M. Hartmann B, et al. Among authors: guba m. Kidney Int. 2005 Dec;68(6):2593-8. doi: 10.1111/j.1523-1755.2005.00731.x. Kidney Int. 2005. PMID: 16316335 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

225 results

Search Page

Filters